반려동물 수술 후 통증 관리 치료제 시장 규모, 점유율 및 성장 분석 : 약제 클래스별, 동물 유형별, 수술 유형별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Companion Animal Postoperative Pain Management Therapeutics Market size was valued at USD 682.5 Million in 2024 and is poised to grow from USD 731.84 Million in 2025 to USD 1285.4 Million by 2033, growing at a CAGR of 7.23% during the forecast period (2026-2033).

The global companion animal postoperative pain management therapeutics market is primarily driven by increasing pet ownership, enhanced veterinary care standards, and ongoing pharmaceutical advancements. This market encompasses various modalities, including analgesics, local anesthetics, and anti-inflammatories, which facilitate quicker and less painful recovery for pets post-surgery. Enhanced pain management not only leads to improved clinical outcomes and fosters better relationships between pet owners and veterinarians but also elevates veterinary practice differentiation, heightening market demand. A notable trend is the shift from traditional opioids and NSAIDs to more targeted, long-acting formulations, including liposomal bupivacaine and meloxicam, as well as the adoption of multimodal pain strategies. Increased investment in sustained-release technologies and improved analgesia solutions presents substantial growth opportunities, particularly in developing markets.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Companion Animal Postoperative Pain Management Therapeutics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Companion Animal Postoperative Pain Management Therapeutics Market Segments Analysis

Global companion animal postoperative pain management therapeutics market is segmented by drug class, animal, surgery type, end-user and region. Based on drug class, the market is segmented into NSAIDs (carprofen, meloxicam), opioids (tramadol, butorphanol), local anesthetics, alpha-2 agonists and others. Based on animal, the market is segmented into dogs and cats. Based on surgery type, the market is segmented into orthopedic surgery, soft tissue surgery and dental surgery. Based on end-user, the market is segmented into veterinary hospitals, veterinary clinics and research institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Companion Animal Postoperative Pain Management Therapeutics Market

The growing focus on animal welfare by veterinary professionals and pet owners has significantly heightened expectations surrounding postoperative care, leading to a surge in the demand for effective pain management therapeutics. Veterinary clinics are increasingly adopting standardized analgesia protocols and investing in advanced analgesics as the emphasis on comfort and quality of life for pets intensifies. As pet owners seek comprehensive pain management solutions from veterinarians, there is a corresponding rise in investment by both providers and manufacturers to develop innovative products that meet these needs. This trend not only results in the creation of more effective pain management options but also enhances their application in veterinary practices, fostering substantial growth within the veterinary market.

Restraints in the Global Companion Animal Postoperative Pain Management Therapeutics Market

Disparities in regional regulatory frameworks and inconsistent approval standards present significant challenges for manufacturers seeking to launch products in the Global Companion Animal Postoperative Pain Management Therapeutics market. Navigating the complexities of varying safety and efficacy protocols, labeling requirements, and post-approval responsibilities increases compliance burdens and hinders timely market introduction. This situation discourages investment in new treatments, particularly affecting smaller organizations that may lack the resources to adeptly handle multiple regulatory processes. Consequently, patients face a limited range of advanced pain management options, leading to slower clinic adoption of these therapies and ultimately constraining the overall growth potential of the market.

Market Trends of the Global Companion Animal Postoperative Pain Management Therapeutics Market

The Global Companion Animal Postoperative Pain Management Therapeutics market is witnessing a significant trend towards the adoption of multimodal analgesia. Veterinarians are increasingly implementing a combination of local anaesthetics, non-opioid medications, and various therapeutic approaches to optimize pain relief post-surgery. This shift encourages the development of comprehensive pain management plans that move away from singular medication reliance, thus promoting quicker recovery for animals. Enhanced standardization of protocols across veterinary specialties, alongside improved training, drives innovation from companies producing complementary products. As a result, there's a growing emphasis on developing diverse medications and perioperative services focused on elevating animal welfare and clinical outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Companion Animal Postoperative Pain Management Therapeutics Market Size by Drug Class & CAGR (2026-2033)

• Market Overview
• NSAIDs (Carprofen, Meloxicam)
• Opioids (Tramadol, Butorphanol)
• Local Anesthetics
• Alpha-2 Agonists
• Others

Global Companion Animal Postoperative Pain Management Therapeutics Market Size by Animal & CAGR (2026-2033)

• Market Overview
• Dogs
• Cats

Global Companion Animal Postoperative Pain Management Therapeutics Market Size by Surgery Type & CAGR (2026-2033)

• Market Overview
• Orthopedic Surgery
• Soft Tissue Surgery
• Dental Surgery

Global Companion Animal Postoperative Pain Management Therapeutics Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Veterinary Hospitals
• Veterinary Clinics
• Research Institutes

Global Companion Animal Postoperative Pain Management Therapeutics Market Size & CAGR (2026-2033)

• North America (Drug Class, Animal, Surgery Type, End-User)
  • US
  • Canada
• Europe (Drug Class, Animal, Surgery Type, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Drug Class, Animal, Surgery Type, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Drug Class, Animal, Surgery Type, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Drug Class, Animal, Surgery Type, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis Inc. (Rimadyl, Galliprant)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health (Onsior)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norbrook Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phibro Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kindred Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aratana Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacira Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bimeda Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Huvepharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Associated British Foods
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nexcyon Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VetDC Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Torigen Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phibro Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations